Pathologic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate
- 30 November 2006
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 32 (9) , 961-963
- https://doi.org/10.1016/j.ejso.2006.06.004
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Gastrointestinal Stromal Tumors (GIST)Published by Taylor & Francis ,2004
- Surgery and Imatinib in the Management of GIST: Emerging Approaches to Adjuvant and Neoadjuvant TherapyAnnals of Surgical Oncology, 2004
- Is there a role for surgery in patients with “unresectable” cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?The American Journal of Surgery, 2003
- Gastrointestinal stromal tumoursBritish Journal of Surgery, 2003
- Gastrointestinal stromal tumors: a spectrum of diseaseSurgical Oncology, 2003
- Clinical management of gastrointestinal stromal tumors: Before and after STI-571Human Pathology, 2002
- Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I studyThe Lancet, 2001
- Gastrointestinal Stromal Tumors: Current Diagnosis, Biologic Behavior, and ManagementAnnals of Surgical Oncology, 2000
- Two Hundred Gastrointestinal Stromal TumorsAnnals of Surgery, 2000
- Prognostic Factors Influencing Survival in Gastrointestinal Leiomyosarcomas Implications for Surgical Management and StagingAnnals of Surgery, 1992